Day One Biopharmaceuticals, Inc. ($DAWN)
Filing Information
| Accession Number | 0001855298-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
36,138
Total Value
$67,447.63
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 3,162 | โ | โ | 53,971 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 3,688 | โ | โ | 57,659 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 3,687 | โ | โ | 61,346 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 4,625 | โ | โ | 65,971 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 17, 2026 | Sale | 5,814 | $11.60 | $67,447.63 | 60,157 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 3,162 | $0.00 | $0.00 | 18,978 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 3,688 | $0.00 | $0.00 | 25,816 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Unit (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 3,687 | $0.00 | $0.00 | 40,565 | Direct | โ | View Details | |
Chief Commercial Officer | Restricted Stock Units (RSU) | Derivative | Feb 15, 2026 | Exercise/Conversion | 4,625 | $0.00 | $0.00 | 69,375 | Direct | โ | View Details |